According to Swedish Orphan Biovitrum's latest financial reports the company's current earnings are $2.45 Billion USD. , an increase over its 2023 earnings that were of $0.39 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | $0.53 B | 36.04% |
2023 | $0.39 B | 6.31% |
2022 | $0.36 B | -9.56% |
2021 | $0.40 B | -21.42% |
2020 | $0.51 B | 9.7% |
2019 | $0.47 B | 33.14% |
2018 | $0.35 B | 86.26% |
2017 | $0.19 B | 42.19% |
2016 | $0.13 B | 698.47% |
2015 | $16.81 M | -140.01% |
2014 | -$42.03 Million | 338.24% |
2013 | -$9.59 Million | -125.59% |
2012 | $37.48 M | -215.13% |
2011 | -$32.56 Million | -1087.77% |
2010 | $3.29 M | -77.19% |
2009 | $14.44 M |